Chemed - CHE Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" CHE shares.
View CHE analyst ratings or view top-rated stocks.

1 Wall Street analysts have issued twelve-month price objectives for Chemed's shares. Their CHE share price forecasts range from $541.00 to $541.00. On average, they expect the company's stock price to reach $541.00 in the next year. This suggests a possible upside of 21.9% from the stock's current price.
View analysts price targets for CHE or view top-rated stocks among Wall Street analysts.

Chemed's stock was trading at $529.04 at the beginning of 2022. Since then, CHE stock has decreased by 16.1% and is now trading at $443.76.
View the best growth stocks for 2022 here.

Chemed saw a decrease in short interest during the month of August. As of August 31st, there was short interest totaling 263,400 shares, a decrease of 7.9% from the August 15th total of 286,000 shares. Based on an average trading volume of 65,000 shares, the days-to-cover ratio is presently 4.1 days. Approximately 1.8% of the company's stock are sold short.
View Chemed's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our CHE earnings forecast.

Chemed Co. (NYSE:CHE) released its earnings results on Wednesday, July, 27th. The company reported $4.84 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.78 by $0.06. The business earned $531.29 million during the quarter, compared to analyst estimates of $538.07 million. Chemed had a net margin of 12.95% and a trailing twelve-month return on equity of 44.64%. The business's quarterly revenue was down .2% on a year-over-year basis. During the same period in the prior year, the company posted $4.60 earnings per share.

Chemed announced a quarterly dividend on Friday, August 5th. Shareholders of record on Monday, August 15th will be paid a dividend of $0.38 per share on Friday, September 2nd. This represents a $1.52 annualized dividend and a yield of 0.34%. The ex-dividend date is Friday, August 12th. This is an increase from the stock's previous quarterly dividend of $0.36.
Read our dividend analysis for CHE.

Chemed (NYSE:CHE) pays an annual dividend of $1.52 per share and currently has a dividend yield of 0.34%. The company has been increasing its dividend for 13 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 8.45%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CHE will have a dividend payout ratio of 7.36% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CHE.

Chemed updated its FY 2022 earnings guidance on Wednesday, August, 3rd. The company provided earnings per share guidance of $19.30-$19.50 for the period, compared to the consensus estimate of $19.47. The company issued revenue guidance of -.

1 employees have rated Chemed Chief Executive Officer Kevin J. McNamara on Glassdoor.com. Kevin J. McNamara has an approval rating of 100% among the company's employees. This puts Kevin J. McNamara in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include AT&T (T), Home Depot (HD), Johnson & Johnson (JNJ), AbbVie (ABBV), Abbott Laboratories (ABT), CVS Health (CVS), Boeing (BA), UnitedHealth Group (UNH), Verizon Communications (VZ) and Chevron (CVX).

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CHE stock can currently be purchased for approximately $443.76.

Chemed (NYSE:CHE) has a market capitalization of $6.61 billion and generates $2.14 billion in revenue each year. The company earns $268.55 million in net income (profit) each year or $17.98 on an earnings per share basis.

The company employs 14,137 workers across the globe.

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The official website for the company is www.chemed.com. The company can be reached via phone at (513) 762-6690 or via fax at 513-762-6590.